|
...manufacturing organization, for the processing and purification of SemBioSys' plant-produced insulin. The contract is part of the company's preparations for its Investigational New Drug Application (IND) and the initiation of clinical trials. Cangene will manufacture insulin for SemBioSys' preclinical and early stage clinical development.
"Obtaining the services of a...
NOTE: All illustrations and photos
have been removed from this article.

More articles from Worldwide Biotech
US FAST-TRACKS PHARMAXIS CYSTIC FIBROSIS DRUG., January 01, 2007 DESPITE BENEFITS, GENE EXPRESSION FACES HURDLES., January 01, 2007 CHINA BIOPHARMACEUTICALS COMPLETES DESLORATADINE TRIALS., January 01, 2007 INEX'S CALIFORNIA HEARING RESCHEDULED TO JANUARY, 2007., January 01, 2007
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|